New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Chiron Real Estate Inc.

XRN

Real Estate Reit Healthcare Facilities

Chiron Real Estate Inc.’s revenue for fiscal 2025 (year ended December 2025) was $148.2 million, up 6.79% from fiscal 2024.

Revenue
+8.34%
EPS
n/m
Free cash flow
n/m
Total debt
−6.76%

Quarter to September 2026, against a year earlier

25.54 0.16 −0.62%

After hours trading: 25.47, down 0.27%, last trade Fri 4:01pm Eastern.

Market cap
$373.3M
P/E
6.8×
Fwd P/E FY26e
7.6×
Dividend yield
9.63%
F-score
4/9
ROIC
1.40%
Net debt / EBITDA
6.6×
Payout ratio
0.7×

Latest quarter Q3 FY2026 · quarter to September 2026

Revenue grew 8.30% on a year earlier, against 4.70% the quarter before.

Q3 FY2026 and the 7 quarters before it
Quarter Revenue, $m Growth, % Op. margin, % EPS, $
Q3 FY26 40 8.3 5.8 (0.43)
Q2 FY26 40 4.7 23.2 4.78
Q1 FY26 38 10.0 23.4 (0.06)
Q4 FY25 38 9.2 24.5 (0.55)
Q3 FY25 37 8.7 24.5 (0.45)
Q2 FY25 38 10.9 22.2 (0.05)
Q1 FY25 35 (1.4) 27.7 0.15
Q4 FY24 35 6.7 18.4 0.10

Against the consensus: revenue beat by 13.6% ($40.3M v $35.5M); adjusted EPS beat by $0.20 ($0.75 v $0.55).

Growth is on the same quarter a year earlier, and EPS is diluted. Negative figures in brackets.

Reports Feb 24, 2027 · Q4 FY26 · consensus EPS $0.41

All quarters →

Capital & Financial Ratios $m

Size
Market Cap 373
Revenue ttm 157
Net income ttm 62
Free cash flow ttm 14
Net debt Q 648
Valuation
P/E 6.8
Forward P/E FY26e 7.6
Price / sales 2.2
Forward P/S FY26e Powerpack
Price / FCF 24.1
Price / book 0.7
Financial health
Current ratio Q 0.7
Debt / equity Q 1.0
Interest coverage Q 0.3
Growth
Revenue growth FY26e +5.5%
EPS growth FY26e +438.2% (at or above 15%: strong)
EPS growth FY27e −154.6% (below 0%: weak)
EPS growth, 5 yrs e +5.8%
Insiders
Net bought 12m 4
Sells 12m 0
Buys 12m 17
Owned by insiders 9.7%

Green and red mark values outside typical ranges; (Q) is the latest quarter; e marks analysts’ estimates, FY26e the fiscal year ending in 2026; n/m is not meaningful, as a P/E on a loss. How we judge →

Compound annual growth

10y 5y 3y
Sales 53.34% 9.60% 2.59%
Cash Flow — 16.35% (1.29%)
Earnings — — —
Book Value — 2.98% (6.53%)

Valuation

P/E against its own 10 years 0.06%
10-year low 10-year high
P/S against its own 10 years 4.57%
10-year low 10-year high
P/B against its own 10 years 5.19%
10-year low 10-year high
EV/Sales against its own 10 years 0.04%
10-year low 10-year high

Dividends

Yield
9.63%
Annual rate
2.46
Payout ratio
65.8%
Growth, 2017–25
−2.97%/yr
  1. 4.20 ’17
  2. 4.00 ’18 −5
  3. 4.00 ’19 +0
  4. 4.00 ’20 +0
  5. 5.13 ’21 +28
  6. 4.20 ’22 −18
  7. 4.20 ’23 +0
  8. 4.20 ’24 +0
  9. 3.30 ’25 −21
  10. 2.39 ’26e −28
paid forecast change on the year, % Powerpack

Analysts’ price targets Wall Street, collected weekly

Analyst price targets

Analysts’ consensus Wall Street average, updated each weekday

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 8 30 53 71 94 116 137 141 139 148 157 +37.9% 156 168 200 +10.5%
Gross margin, % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 0.0 pt
EBT (6) 0 15 10 (2) 18 20 22 7 (7) 62 n/m
EBT margin, % (77.37) (0.29) 27.37 13.56 (2.67) 15.82 14.57 15.41 4.82 (4.64) 39.64 +72.7 pt
Net income (6) 0 15 10 (2) 18 20 22 7 (7) 62 n/m
Per share, $
Per share, $ Revenue 4.41 7.73 12.11 10.44 10.13 9.56 10.49 10.76 10.52 11.08 11.82 +10.8%
Earnings (3.40) (0.45) 1.75 0.50 (0.85) 0.95 1.00 1.15 0.05 (0.91) 3.74 n/m
Cash flow (1.16) 3.21 5.65 5.38 3.73 5.69 5.85 5.22 5.31 5.50 5.36 n/m
Capex (80.95) (64.31) (34.52) (37.92) (23.65) (16.18) (10.56) 5.25 (2.86) (4.39) (4.29) (27.7%)
Free cash flow (82.11) (61.10) (28.87) (32.54) (19.92) (10.49) (4.72) 10.47 2.45 1.11 1.06 n/m
Book value 83.33 66.02 68.21 67.97 49.48 52.57 49.58 46.21 42.16 39.62 51.38 (7.9%)
Shares, m 2 4 4 7 9 12 13 13 13 13 13 +24.5%
Valuation, ×
Valuation, × P/E n/m n/m 26.15 132.30 n/m 93.42 47.05 47.83 772.00 n/m 6.83 186.5
P/S 10.12 5.49 3.67 6.33 6.45 9.28 4.49 5.11 3.67 3.05 2.16 5.8
P/B 0.54 0.90 0.87 1.16 1.58 1.91 1.07 1.36 1.06 1.11 0.74 1.2
EV/Sales 11.14 10.70 8.87 11.26 11.94 13.65 9.06 9.24 8.18 7.39 6.30 10.1
EV/FCF (0.60) (1.35) (3.72) (3.61) (6.07) (12.44) (20.13) 9.49 35.15 73.65 70.16 7.0
Cash, $m
Cash, $m Operating cash flow (2) 13 25 36 35 69 77 68 70 74 71 n/m
Capex (151) (252) (152) (257) (219) (196) (138) 69 (38) (59) (57) (9.9%)
Free cash flow (153) (240) (127) (220) (184) (127) (62) 137 32 15 14 n/m
Balance, $m
Balance, $m Working capital (19) (33) (37) (37) (61) (55) (57) (32) (22) (8) (7) n/m
Net debt 8 158 277 348 515 506 627 582 626 644 648 +62.0%
Shareholders’ equity 155 259 300 460 458 638 649 606 556 530 680 +14.6%
Returns, %
Returns, % ROA (4.34) (0.50) 1.38 0.45 (0.78) 1.00 1.00 1.11 0.06 (0.97) 3.46 +3.4 pt
ROIC 0.04 1.48 2.37 2.09 1.04 2.02 1.88 2.00 1.74 1.95 1.40 +1.9 pt
ROE (8.20) (1.03) 3.75 1.12 (2.02) 2.50 2.34 2.68 0.16 (2.73) 10.38 +5.5 pt
People
People Employees 10 9 2 2 22 26 29 26 26 30 — +13.0%
Revenue/emp, $m 0.82 3.37 26.60 35.36 4.26 4.46 4.73 5.42 5.34 4.94 — +22.1%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated Nov 11, 2026

Chiron Real Estate Inc. vs peers in Reit Healthcare Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NHI National Health Investors, Inc. $3.0B 4.3× 4.5× FY26e +26.31% (above 0%: growing) +1,564.39% (above 0%: growing) +782.13% (above 0%: growing) 68.11% 26.23% Compare
LTC LTC Properties, Inc. $2.4B 4.4× 5.4× FY26e +66.32% (above 0%: growing) n/m −126.46% (below 0%: shrinking) 100.00% 303.46% Compare
DHC Diversified Healthcare Trust $1.7B — (loss-making) — (loss-making) −5.41% (below 0%: shrinking) n/m +100.70% (above 0%: growing) 21.97% (3.97%) Compare
NHP National Healthcare Properties, Inc. $985.7M — (loss-making) 16.2× FY26e +19.80% (above 0%: growing) n/m −966.55% (below 0%: shrinking) 32.49% 30.87% Compare
MPT Medical Properties Trust, Inc. $959.9M 4.2× 4.9× FY26e +5.31% (above 0%: growing) n/m +756.45% (above 0%: growing) 95.44% (5.49%) Compare
STRW Strawberry Fields REIT, Inc. $678.3M 52.3× 45.0× FY26e +0.70% (above 0%: growing) n/m +106.63% (above 0%: growing) 91.05% 58.43% Compare
UHT Universal Health Realty Income Trust $516.5M 25.5× 31.2× FY26e +0.17% (above 0%: growing) +20.69% (above 0%: growing) −119.49% (below 0%: shrinking) 94.23% 35.35% Compare
CHCT Community Healthcare Trust Incorporated $410.7M 19.5× 36.8× FY26e +4.37% (above 0%: growing) +200.00% (above 0%: growing) +151.08% (above 0%: growing) 81.58% 35.78% Compare
XRN Chiron Real Estate Inc. $373.3M 6.8× 7.6× FY26e +8.34% (above 0%: growing) n/m −131.53% (below 0%: shrinking) 100.00% 5.77%
Median of peers $972.8M 11.9× 16.2× +4.84% +200.00% +103.66% 86.32% 33.11%

All 17 Reit Healthcare Facilities stocks →

Pay and ownership Proxy statement filed Apr 8, 2026

Ownership

Directors and executive officers, together 8.90%
BlackRock, Inc. 7.90%
Zhang Huiqi 5.70%
Zensun Enterprises Limited 5.60%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Chiron Real Estate Inc. (XRN) Latest News

What happened

  1. Other Chiron Real Estate pursued a sale of its outpatient medical portfolio, worth about $1.5 billion, while shifting investment toward seniors housing.
16 more headlines
All XRN news, as stories →
stockrow.com/XRN · Data as of Nov 11, 2026 · For information only; not investment advice. · © 2026 stockrow.com